Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT06019975
Recruiting Observational

FDG-PET in the Diagnosis of Autoimmune Encephalitis

NCT06019975 · tracked via the Priya Life Science Italy tracker
Sponsor
University of Milano Bicocca
Phase
Observational
Started
2023-03-01
Last updated
2026-03-24

Condition(s) studied

Autoimmune Encephalitis

Investigational drug(s) / intervention(s)

FDG-PET

FDG-PET: Brain FDG-PET

Study summary

The goal of this retrospective observational study is to compare brain fluorodeoxyglucose-positron emission tomography (FDG-PET) of patients with autoimmune encephalitis, normal controls and patients with Alzheimer's disease (AD). The main question it aims to answer is:

•is there a specific pattern of brain metabolism in patients with autoimmune encephalitis Participants data and images will be retrospectively collected from hospital records, and FDG-PET images will be analyzed by means of statistical parametric mapping (SPM). Controls will be selected from validated public databases.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of autoimmune encephalitis according to clinical criteria * Brain magnetic resonance imaging performed between clinical presentation and treatment * Cerebrospinal fluid analysis performed between clinical presentation and treatment * Brain FDG-PET performed between clinical presentation and treatment * Autoantibodies testing performed between clinical presentation and treatment Exclusion Criteria: * Refusal to give consent for the study

Primary outcome measure(s)

Trial sites (6)

FacilityCityRegionStatus
Azienda Sanitaria Universitaria Friuli Centrale Udine Friuli Venezia Giulia Not Yet Recruiting
IRCCS Ospedale Policlinico San Martino Genoa Liguria Not Yet Recruiting
Fondazione IRCCS Mondino Pavia Lombardy Recruiting
Fondazione IRCCS Istituto Neurologico "Carlo Besta" Milan Milano Not Yet Recruiting
Ospedale San Paolo Milan Milano Not Yet Recruiting
Fondazione IRCCS San Gerardo dei Tintori Monza Monza e Della Brianza Recruiting

More University of Milano Bicocca trials in Italy

Prospective Observational Study Based on a Cohort of Geriatric Patients With Hip Fracture Treated in the Centers Belonging to the GIOG Group Recruiting
Hepatocarcinoma Recurrence on the Liver Study - Part2 Starting soon
Optimizing Prevention of Hospital-Acquired Disability Through Multidomain Interventions Recruiting
Non-invasive Vibratory Stimulation of the Knee Muscles for the Improvement of the Somatosensory Input and Motor Performance Recruiting
Vancomycin in Primary Sclerosing Cholangitis in Italy Recruiting

Other trials for the same condition

Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06019975 on ClinicalTrials.gov ↗ ← All trials in Italy